We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TZOO:NASDAQTravelzoo Analysis

Data as of 2026-06-10 - not real-time

$10.04

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading above its short‑term moving averages, keeping the broader trend bullish, while the RSI sits in the upper‑mid range, indicating still‑healthy momentum. However, the MACD has turned bearish, hinting at a possible short‑term pullback, and the share price is approaching a key resistance zone. Elevated volatility and a beta above the market suggest the price could swing sharply on new information.
Fundamental backdrop: The company enjoys very high gross margins and solid operating profitability, supported by positive operating and free cash flow. Earnings are expected to accelerate sharply, as reflected by a forward price‑to‑earnings multiple that is far lower than the current trailing multiple and well below industry peers. A discounted cash‑flow model places fair value modestly below the current price, implying a slight overvaluation at present, yet analyst consensus targets are substantially higher, indicating that the market may already be pricing in future growth. The recent launch of new travel club offers adds a fresh revenue catalyst that could enhance member engagement and top‑line growth.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish trend still in place
  • Bearish MACD crossover suggests caution
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward earnings expected to rise sharply
  • Strong margins and cash generation
  • Analyst price targets imply sizable upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable high gross margins
  • Continued expansion of travel‑club offerings
  • Long‑term tailwinds in digital travel content

Key Metrics & Analysis

Financial Health

Revenue Growth4.90%
Profit Margin4.32%
P/E Ratio26.4
ROA8.18%
P/B Ratio-13.2
Op. Cash Flow$6.2M
Free Cash Flow$5.6M
Industry P/E17.0

Technical Analysis

TrendBullish
RSI58.0
Support$8.72
Resistance$10.96
MA 20$9.84
MA 50$8.67
MA 200$7.86
MACDBearish
VolumeStable
Fear & Greed Index83.41

Valuation

Fair Value$9.18
Target Price$21.25
Upside/Downside111.65%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.34
Volatility47.32%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.